B-cell chronic lymphocytic leukemia (B-CLL), also known as chronic lymphoid leukemia (CLL), is the most common type of leukemia (a type of cancer of the white blood cells) in adults, CLL affects B cell lymphocytes,Immunoglobulin-like transcript-3 (ILT-3), a member of the immunoglobulin superfamily, is a transmembrane inhibitory receptor expressed on antigen-presenting cells (APCs) such as monocytes and dendritic cells (DCs) as well as on endothelial cells The aims of this study was to evaluate the expression of ILT-3 in acute and chronic leukamias and its relation to other diagnostic markers and if it has a role in leukamiogenesis A total of 5 papers were obtained using the mentioned keywords in the research of all internet-based databases Patients and Methods: Case control study, included 30 patients 15 patients with CLLand 15patients no detectable disease recruited from Sohag university hospital and the mean age of each of them was 32.8 years. There are different method of detection of IL3 in different studies such as PCR, ELISA and (FCM). Results: The frequency of ILT3 positive CLL B cells was higher in patients with lymphoid tissue involvement, suggesting that ILT3 may have prognostic value in CLL
Introduction
In CLL, B cells grow in an uncontrolled manner and accumulate in the bone marrow and blood, where they crowd out healthy blood cells, CLL is a stage of small lymphocytic lymphoma (SLL), a type of B-cell lymphoma, which presents primarily in the lymph nodes, CLL and SLL are considered the same underlying disease, just with different appearances (Lichtmanet al,2011).
Immunoglobulin-like transcript-3 (ILT-3), a member of the immunoglobulin superfamily, is a transmembrane inhibitory receptor expressed on antigen-presenting cells (APCs) such as monocytes and dendritic cells (DCs) as well as on endothelial cells encoded in the leukocyte receptor cluster on human chromosome 19 (Deng et al , 2014).
They are structurally and functionally related to other leukocyte receptor cluster receptors, such as the killer cell immunoglobulin-like receptors, and have been reported to regulate a broad range of cells involved in the immune response (Morel and Bello´n, 2011).
Objectives:
To study the expression of ILT-3 in chronic lymphocytic leukamia and its relation to other diagnostic markers and if it has a role in leukamiogenesis .
Patients and methods:
Patients:This, studyconducted on two groups:Group 1: available number of patientswithchronic,Lymphoblasticleu kemia with different both (age, sex). Group 2: about 15 case ITP subjected to bone marrow aspiration.
All patients,and control cases will be subjected to: • Full history taking.
• Clinical examination.
• Laboratory investigation include:
• Complete blood count.
• BM examination (BMA, BMB) .
• Routine immunophenotyping panel for diagnosis of acute and chronic leukemia.
• ILT-3 expression of the peripheral blood or BM aspirate using flow cytometer.
Results of the study
This study was carried on 15 cases with leukemia 6 Males , 9 females , their ages ranged from 50 to 74 yearsSamples were collected from oncology clinic of sohag universityData was analyzed using STATA intercooled version 12.1. Quantitative data was represented as mean, standard deviation, median and range. Data was analyzed using student t-test to compare means of two groups and ANOVA for comparison of the means of three groups or more. In this study The expression of ILT3 isabsent in control group,ILT3 expressed in 6 patients(50%) in CLL groupas by more differentiated CD34-CD117-CD14 /-leukemic cells.
Conclusion
The frequency of ILT3 positive CLL B cells was higher in patients with lymphoid tissue involvement, suggesting that ILT3 may have prognostic value in CLL.
